| Product Code: ETC6892624 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of Cyprus for deoxyribonucleic acid (DNA) and gene chips (microarrays) have seen significant growth, with a high Herfindahl-Hirschman Index (HHI) indicating market concentration. In 2024, top exporting countries include Metropolitan France, Belgium, Denmark, UK, and USA. The compound annual growth rate (CAGR) from 2020 to 2024 stands at an impressive 110.54%, with a notable growth rate of 52.24% from 2023 to 2024. This suggests a strong demand for genetic research and diagnostics in Cyprus, driving the import of these specialized products.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Overview |
3.1 Cyprus Country Macro Economic Indicators |
3.2 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, 2021 & 2031F |
3.3 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market - Industry Life Cycle |
3.4 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market - Porter's Five Forces |
3.5 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Technological advancements in DNA and gene chip technology |
4.2.2 Growing demand for personalized medicine and precision healthcare |
4.2.3 Increasing research and development activities in genomics and genetics |
4.3 Market Restraints |
4.3.1 High costs associated with DNA and gene chip technologies |
4.3.2 Lack of skilled professionals in the field of genomics and genetics |
4.3.3 Ethical and regulatory concerns related to genetic testing and data privacy |
5 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Trends |
6 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By Types |
6.1 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.4 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Instrumentation, 2021- 2031F |
6.2 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Oligonucleotide DNA Microarrays (oDNA), 2021- 2031F |
6.2.3 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Complementary DNA Microarrays (cDNA), 2021- 2031F |
6.3 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Gene Expression, 2021- 2031F |
6.3.3 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Cancer Diagnosticsand Treatments, 2021- 2031F |
6.3.4 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Drug Discovery, 2021- 2031F |
6.3.5 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Genetics, 2021- 2031F |
6.3.6 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By SNP Analysis, 2021- 2031F |
6.3.7 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Screening and Monitoring Of Patient Data DuringClinical Trials, 2021- 2031F |
6.3.8 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Other, 2021- 2031F |
6.3.9 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F |
6.4.3 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Biotechnological and Pharmaceutical Companies, 2021- 2031F |
6.4.4 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenues & Volume, By Research Laboratories, 2021- 2031F |
7 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Import-Export Trade Statistics |
7.1 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Export to Major Countries |
7.2 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Imports from Major Countries |
8 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Key Performance Indicators |
8.1 Adoption rate of DNA and gene chip technologies in healthcare facilities and research institutions |
8.2 Number of research publications utilizing DNA and gene chip technologies |
8.3 Rate of investment in genomics and genetics research and development |
9 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market - Opportunity Assessment |
9.1 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market - Competitive Landscape |
10.1 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Revenue Share, By Companies, 2024 |
10.2 Cyprus Deoxyribonucleic Acid (DNA) and Gene Chip (Microarrays) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |